Current Status of HBV Therapy | Pietro Lampertico, MD, PhD

International Workshop on HBV Cure 2016

Last advances in HIV pharmacogenomics - Andrea Calcagno, MD, DTM&H

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Deprescribing Polypharmacy - Catia Marzolini, PharmD, PhD.pdf

International Workshop on Aging & HIV 2024

Clinical progress of the entry inhibitor Myrcludex B | Stephan Urban

International Workshop on HBV Cure 2018

Hapatitis C Reinfection after Sustained Virological Response in HIV/HCV Co-Infected Patients | Fábio Videira Santos

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Sustained SVR 2 years after HCV treatment with simeprevir, daclatasvir and sofosbuvir in patients with portal hypertension or decompensated liver disease (not available)- Dr. E. Lawitz

HEP DART 2017

Management of end-stage liver disease in HIV patients- Ana Morbey, MD

International Workshop on HIV & Hepatitis Co-infection 2017

Pharmacological perspective- José Moltó, MD, PhD

Spanish HIV Clinical Forum 2017

How should we optimize immunosuppression? - Kittie Wynne, MD, PhD

Symposium on Key Issues in Liver Transplantation for NASH 2016

In silico pharmacokinetic/pharmacodynamic simulation of long acting tenofovir injectable formulation for pre exposure prophylaxis strategies - Dr. Paul Curley

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016